Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Parents know fruit and vegetables are healthy, but many underestimate how much children need

15

Oct 2026

Parents know fruit and vegetables are healthy, but many underestimate how much children need

A qualitative study involving 15 Swedish parents found that although most recognized the health benefits of fruit and vegetables, many underestimated recommended daily intake and considered serving vegetables at dinner sufficient. Researchers identified four overlapping parental roles influencing children's eating habits and suggested that clearer guidance on quantities, serving frequency, and practical feeding approaches could help families improve consumption.

AI study of 101,000 patients links brown fat to heart and mental health

15

Oct 2026

AI study of 101,000 patients links brown fat to heart and mental health

In a retrospective analysis of PET-CT records from 101,243 patients, researchers found that detectable brown fat was associated with lower prevalence of cardiometabolic and psychiatric conditions, while greater activity, particularly in the axillary region, was linked to more favourable metabolic outcomes. Medication screening identified losartan, which increased brown fat thermogenic activity in laboratory experiments and energy expenditure in mice, although its effects on human brown fat remain unproven.

Scientists discover water-triggered reactions that may explain microplastic harm

15

Oct 2026

Scientists discover water-triggered reactions that may explain microplastic harm

Researchers found that six common types of microplastics spontaneously generate reactive oxygen species at their interfaces with water, with more hydrophobic plastics showing greater chemical activity. Laboratory experiments also linked these surface properties to biomolecular adsorption, protein aggregation, and mouse red blood cell damage, although the implications for human health remain uncertain.

Women with low bone density reported less pain after taking pine bark extract

15

Oct 2026

Women with low bone density reported less pain after taking pine bark extract

A randomized clinical trial involving 67 women with osteopenia or stable osteoporosis found that three months of Pycnogenol® supplementation improved self-reported bodily pain and vitality scores compared with placebo. However, overall disease-specific quality of life did not significantly improve, and the six-month findings were insufficient to establish long-term benefits or safety.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.